Trinucleotide repeat expansion and human disease

Annual Review of Genetics

Volumn 29, Issue , 1995, Pages 703-728

  Ashley Jr , Claude T ^a   Warren, Stephen T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dynamic mutations; fragile sites; genetic anticipation; genome instability; mental retardation; neurodegenerative disease; trinucleotide repeat

Indexed keywords

GLUTAMINE; REPETITIVE DNA; TRINUCLEOTIDE;

CHROMOSOME 11; CHROMOSOME 16; CHROMOSOME FRAGILE SITE; CODON; DEGENERATIVE DISEASE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; FACIAL NERVE DISEASE; FRAGILE X SYNDROME; GENE LOCUS; HUMAN; HUNTINGTON CHOREA; MACHADO JOSEPH DISEASE; MEIOSIS; MYOTONIC DYSTROPHY; PENETRANCE; PRIORITY JOURNAL; REVIEW; SPINOCEREBELLAR DEGENERATION;

EID: 0029584496     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.ge.29.120195.003415     Document Type: Review

References (206)

1. Abeliovich D, Lerer I, Pashut-Lavon I, Shmueli E, Raas-Rothschild A, Frydman M. 1993. Negative expansion of the myotonic dystrophy unstable sequence. Am. J. Hum. Genet. 52:1175-81
2. Abitbol M, Menini C, Delezoide A-L, Rhyner T, Vekemans M, Mallet J. 1993. Nucleus basal is magnolaris and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat. Genet. 4:147-52
3. Albin RL, Tagle DA. 1995. Genetics and molecular biology of Huntington's disease. Trends Neurosci. 18:11-14
4. Allingham-Hawkins DJ, Ray PN. 1995. FRAXE expansion is not a common etiological factor among developmentally delayed males. Am. J. Hum. Genet. 56:72-76
5. Ambrose CM, Duyao MP, Barnes G. Bates GP, Lin CS, et al. 1994. Structure and expression of the Huntinglon's disease gene: evidence against simple inactivation due to an expanded CAO repeat. Somat. Cell Mol. Genet. 20:27-38
6. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, et al. 1993. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4:398-403
7. Anvret M, Ahlberg G, Grandell U, Hedberg B, Johnson K, Edstrom L. 1993. Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum. Mol. Genet. 2:1397-400
8. Armour JAL, Jeffreys AJ. 1992. Biology and applications of human minisatellite loci. Curr. Opin. Genet. Dev. 2:850-56
9. Ashizawa T, Anvret M, Baiget M, Barcelo JM, Brunner H, et al. 1994. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am. J. Hum. Genet. 54:414-23
10. Ashley CT, Sutcliffe JS, Kunst CB, Leiner HA, Eichler EE, et al. 1993. Human and murine FMR-I. alternative splicing and translational initiation downstream of the CGG-repeat. Nat. Genet. 4:244-51
11. Ashley CT, Wilkinson KD, Reines D, Warren ST. 1993. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-66
12. Banfi S, Servadio A, Chung M-y, Kwiatkowski TJ Jr, McCall AE, et al. 1994. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet. 7:513-20
13. Baxendale S, Abdulla S, Elgar G, Buck D, Berks M, et al. 1995. Comparative sequence analysis of the human and pufferfish Huntington's disease genes. Nat. Genet. 10:67-76
14. Bell MV, Hirst MC, Nakahori Y, MacKinnon RN, Roche A, et al. 1991. Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell 64:861-66
15. Biancalana V, Serville F, Pommier J, Hanauer A, Mandel JL. 1992. Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy. Hum. Mol. Genet. 1:255-58
16. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, et al. 1995. Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat. Genet. 9:191-96
17. Blake TJ, Shapiro M, Morse HC, Langdon WY. 1991. The sequence of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653-57
18. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808
19. Brunner HG, Jansen G, Nillesen W, Nelen MR, de Die CEM, et al. 1993. Reverse mutation in myotonic dystrophy. N. Engl. J. Med. 328:476-80
20. Brunner HG, Nillesen W, van Oost BA, Jansen G, Wieringa B, et al. 1992. Presymptomatic diagnosis of myotonic dystrophy. J. Med. Genet. 29:780-84
21. Burke JR, Ikeuchi T, Koide R, Tsuji S, Yamada M, et al. 1994. Dentatorubralpallidoluysian atrophy and Haw River syndrome. Lancet 344:1711-12
22. Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, et al. 1994. The Haw River syndrome: dentatorubropallidoluysian atrophy in an African American family. Nat. Genet. 7:521-24
23. Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, et al. 1992. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355:547-51
24. Carango P, Noble EN, Marks HG, Funanage VL. 1993. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of triplet repeat expansion in myotonic dystrophy. Genomics 18:340-48
25. Carey N, Johnson K, Nokelainen P, Peltonen L, Savontaus M-L, et al. 1994. Meiotic drive at the myotonic dystrophy locus. Nat. Genet. 6:117-18
26. Chen X, Mariappan SVS, Catasti P, Ratliff R, Moyzis RK, et al. 1995. Hairpens are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc. Natl. Acad. Sci. USA 92:5199-203
27. Chung M-y, Ranum LPW, Duvick LA, Servadio A, Zoghbi HY, Orr HT. 1993. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat. Genet. 5:254-58
28. Consortium D-BFX. 1994. FMR1 knockout mice: a model to study fragile X mental retardation. Cell 78:23-33
29. De Boulle K, Verkerk AJMH, Reyniers E, Vits L, Hendrickx J, et al. 1993. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3(1):31-35
30. de Die-Smulders CEM, Howeler CJ, Mirandolle JF, Brunner HG, Hovers V, et al. 1994. Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family. J. Med. Genet. 31:595-601
31. Dennis N, Curtis G, Macpherson J, Jacobs P, Heitz D. 1992. Two families with Xq27.3 fragility, no detectable insert in the FMR-1 gene, mild mental impairment and absence of Martin-Bell phenotype. Am. J. Med. Genet. 43:232-36
32. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons, and appears normal in carriers of the fragile X premutation. Nat. Genet. 4:335-40
33. DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, et al. 1995. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075-81
34. Doerfler W. 1992. DNA methylation: eukaryotic defense against the transcription of foreign genes? Microb. Pathol. 12:1-8
35. Doyu M, Sobue G, Mukai E, Kachi T, Yasuda T, et al. 1992. Severity of X-linked recessive bulbospinal neuro- nopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann. Neurol. 32:707-10
36. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, et al. 1993 Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet. 4:387-92
37. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, et al. 1995 Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407-10
38. Eichler EE, Holden JJA, Popovich BW, Reiss AL, Snow K, et al. 1994. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat. Genet. 8:88-94
39. Eichler EE, Kunst CB, Lugenbeel KA, Ryder OA, Davison D, et al. 1995. Evolution of the cryptic FMR1 CGG repeat. Nat. Genet. In press
40. Eichler EE, Richards S, Gibbs RA, Nelson DL. 1993. Fine structure of the human FMR1 gene. Hum. Mol. Genet. 2:1147-53
41. Farmer TW, Wingfield MS, Lynch SA, Vogel FS, Hulette C, et al. 1989. Ataxia, chorea, seizures, and dementia: pathologic features of a newly defined familial disorder. Arch. Neurol. 46:774-79
42. Feng Y, Lakkis L, Devys D, Warren ST. 1995. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am. J. Hum. Genet. 56:106-13
43. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, et al. 1995. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-34
44. Fisch GS, Snow K, Thibodeau SN, Chalifaux M, Holden JJA, et al. 1995. The fragile X premutation in carriers and its effect on mutation size in offspring. Am. J. Hum. Genet. 56:1147-55
45. Fischbeck KH, Souders D, La Spada AR. 1991. A candidate gene for X-linked spinal muscular atrophy. Adv. Neurol. 56:209-14
46. Flynn GA, Hirst MC, Knight SJL, Macpherson JN, Barber JCK, et al. 1993. Identification of the FRAXE fragile site in two families ascertained for X-linked mental retardation. J. Med. Genet. 30:97-100
47. Fry M, Loeb LA. 1994. The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. USA 91:4950-54
48. Fu Y-H, Friedman DL, Richards S, Pearlman JA, Gibbs RA, et al. 1993. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260:235-38
49. Fu Y-H, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, et al. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-58
50. Fu Y-H, Pizzuti A, Fenwock RG, King J, Rajnarayan S, et al. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-58
51. Gedeon AK, Keinanen M, Ades LC, Kaarlainen H, Gecz J, et al. 1995. Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am. J. Hum. Genet. 56:907-14
52. Gerber H-P, Seipel K, Georgiev O, Hofferer M, Hug M, et al. 1994. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:808-11
53. Goldberg YP, Andrew SE, Theilmann J, Kremer B, Squitieri F, et al. 1993. Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases. J. Med. Genet. 30:987-90
54. Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, et al. 1993. Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat. Genet. 5:174-79
55. Goldman A, Ramsay M, Jenkins T. 1994. Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. J. Med. Genet. 31:37-40
56. Green H. 1993. Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74:955-56
57. Group THDCR. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-83
58. Gusella JF, MacDonald ME, Ambrose CM, Duyao MP. 1993. Molecular genetics of Huntington's disease. Arch. Neurol. 50:1157-63
59. Hagerman RJ, Silverman AC, eds. 1991. Fragile X Syndrome, Diagnosis, Treatment and Research. Baltimore: Johns Hopkins Univ, Press
60. Hamel BCJ, Smits APT, de Graaff E, Smeets DFCM, Scheute F, et al. 1994. Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am. J. Hum. Genet. 55:923-31
61. Hansen RS, Gartler SM, Scott CR, Chen S-H, Laird CD. 1992. Methylation analysis of COG sites in the CpG island of the human FMR1 gene. Hum. Mol. Genet. 1(8):571-78
62. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, et al. 1992. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355:545-46
63. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, et al. 1993. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am. J. Hum. Genet. 52:1164-74
64. Harper PS. 1989. Myotonic dystrophy and related disorders. In Principles and Practice of Medical Genetics, ed. A Emery, D Rimoin, 2:579-97. London: WB Saunders
65. Harper PS. 1991. The epidemiology of Huntington's disease. In Huntington's Disease, ed. PS Harper, pp. 251-80. London: Saunders
66. Harper PS, Harley HG, Reardon W, Shaw DJ. 1992. Anticipation in myotonic dystrophy: new light on an old problem. Am. J. Hum. Genet. 51:10-16
67. Hedreen JC, Peyser CE, Folstein SE, Ross CA. 1991. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133:257-61
68. Hergersberg M, Matsuo K, Gassman M, Schaffner W, Luscher B, et al. 1995. Tissue-specific expression of a FMR1/B-galactosidase fusion gene in transgenic mice. Hum. Mol. Genet. 4:359-66
69. Hinds HL, Ashley CT, Nelson DL, Warren ST, Housman DE, Schalling M. 1993. Tissue specific expression of FMR1 provides evidence for a functional role in fragile X syndrome. Nat. Genet. 3:36-43
70. Hirst MC, Barnicoat A, Flynn G, Wang Q, Daker M, et al. 1993. The identification of a third fragile site, FRAXF, in Xq27-Xq28 distal to both FRAXA and FRAXE. Hum. Mol. Genet. 2:197-200
71. Hirst MC, Grewal PK, Davies KE. 1994. Precursor arrays for triplet repeat expansion at the fragile X locus. Hum. Mol. Genet. 3:1553-60
72. Hoogeveen AT, Willemsen R, Meyer N, de Rooij KE, Roos RAC, et al. 1993. Characterization and localization of the Huntington disease gene product Hum. Mol. Genet. 2:2069-73
73. Hornstra IK, Nelson DL, Warren ST, Yang TP. 1993. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum. Mol. Genet. 2(10):1659-65
74. Howeler C, Busch HFM, Geraedts JPM, Niermeijer MF, Staal A. 1989. Anticipation in myotonic dystrophy: fact or fiction. Brain 112:779-97
75. Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, et al. 1992. Strong correlation between the number of CAG repeats in androgen receptor genes and clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300-2
76. Illarioshkin SN, Igarashi S, Onodera O, Markova ED, Nikolskaya NN, et al. 1994. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann. Neurol. 36:630-35
77. Imbert G, Kretz C, Johnson K, Mandel J-L. 1993. Origin of the expansion mutation in myotonic dystrophy. Nat. Genet. 4:72-76
78. Jacobsen P, Hauge M, Henningsen K, Hobolth N, Mikkelsen M, Philip J. 1973. An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. Hum. Hered. 23:568-85
79. Jansen G, Mahadevan M, Amemiya C, Workskamp N, Segers B, et al. 1992. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat. Genet. 1:261-66
80. Jansen G, Willems P, Coerwinkel M, Nillesen W, Smeets H, et al. 1994. Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am. J. Hum. Genet. 54:575-85
81. Jodice C, Malaspina P, Persichetti F, Novelletto A, Sparado M, et al. 1994. Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar alaxia I. Am. J. Hum. Genet. 54:959-65
82. Jones C, Penny L, Mattina S, Yu E, Baker L, et al. 1995. The fragile site FRA11B, in protooncogene CBL2, is associated with a chromosome deletion syndrome. Science. In press
83. Jones C, Slijepcevic P, Marsh S, Baker E, Langdon WY, et al. 1994. Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum. Mol. Genet. 3:2123-30
84. Jou Y-S, Myers RM. 1995. Evidence from antibody studies that the CAG repeat in the Huntington's disease gene is expressed in the protein. Hum. Mol. Genet. 4:465-69
85. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, et al. 1994. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8:221-28
86. Kazemi-Esfarjani P, Trifiro MA, Pinsky L. 1995. Evidence for a repressive function of the long polyglulamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum. Mol. Genet. 4:523-27
87. Keller W. 1995. No end yet to messenger RNA 3′ processing. Cell 81:829-32
88. Kennedy WR, Alter M, Sung JH. 1968. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 18:671-80
89. Khandjian EW, Fortin A, Thihodeau A. Tremblay S, Cote F, et al. 1995. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum. Mol. Genet. 4:783-89
90. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, et al. 1993. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-34
91. Knight SJL, Voelckel MA, Hirst MC, Flannery AV, Moncla A, Davies KE. 1994. Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am. J. Hum. Genet. 55:81-86
92. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, et al. 1994. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 6:9-13
93. Kremer B, Goldberg P, Andrew SE. Theilmann J, Telenius H, et al. 1994. A worldwide study of the Huntington's disease mutation. N. Engl. J. Med. 330:1401-6
94. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, et al. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-14
95. Kunst CB, Warren ST. 1994. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 77:853-61
96. LaSpada AR, Roling DB, Harding AE, Warner CL, Spiegel R, et al. 1992. Meiotic stability and genotype-phenotype correlation of the trinucleotide re- peat in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 2:301-4
97. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. 1991. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
98. Lavedan C, Hofmann-Radvanyi H, Boileau C, Bonaiti-Pellie C, Savoy D, et al. 1994. French myotonic dystrophy families show expansion of a CTG repeat in complete linkage disequilibrium with an intragenic 1 kb insertion. J. Med. Genet. 31:33-36
99. Lavedan C, Hofmann-Radvanyi H, Rabes JP, Roume J, Junien C. 1993. Different sex-dependent constraints in CTG length variation as explanation for congenital myotonic dystrophy. Lancet 341:236-37
100. Li S-H, McInnis MG, Margolis RL, Amonarakis SE, Ross CA. 1993. Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics 16:572-79
101. Li S-H, Schilling G, Young WS III, Li X-J, Margolis RL, et al. 1993. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11:985-93
102. Lin B, Nasir J, MacDonald H, Hutchinson G, Graham RK, et al. 1994. Sequence of the murine huntington disease gene: evidence for conservation, and polymorphism in a triplet (CCG) repeat alternate splicing. Hum. Mol. Genet. 3:85-92
103. Lindblad K, Nylander P-O, De Bruyn A, Sourey D, Zander C, et al. 1995. Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiol. Dis. In press
104. Loesch DZ, Muggins R, Hay DA, Gedeon AK, Mulley JC, Sutherland GR. 1993. Genotype-phenotype relationships in fragile X syndrome: a family study. Am. J. Hum. Genet. 53:1064-73
105. Lucotte G, Turpin JC, Riess O, Epplen JT, Siedlaczk I, et al. 1995. Confidence intervals for predicted age of onset, given the size of (CAG)n repeal, in Huntington's disease. Hum. Genet. 95:231-32
106. MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, et al. 1993. Gametic but not somatic instability of CAG repeat length in Huntington's disease. J. Med Genet. 30:982-86
107. Maciel P, Caspar C, DeStefano AL, Silveira I, Coutinho P, et al. 1995. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am. J. Hum. Genet. 57:54-61
108. MacLean HE, Choi W-T, Rekaris G, Warne GL, Zalac JD. 1995. Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy). J. Clin. Endocrinol. Metab. 80:508-16
109. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, et al. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253-55
110. Mahadevan MS, Amemiya C, Jansen G, Sabourin L, Baird S, et al. 1993. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum. Mol. Genet. 2:299-304
111. Maruyama H, Nakamura S, Matsuyama Z, Sakai T, Doyu M, et al. 1995. Molecular features of the CAG repeats and clinical manifestation of MachadoJoseph disease. Hum. Mol. Genet. 4:807-12
112. Matilla T, Volpini V, Genis D, Rosell J, Corral J, et al. 1993. Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG-repeat in a large pedigree displaying anticipation and parental male bias. Hum. Mol. Genet. 2:2123-28
113. McConkie-Rosell A, Lachiewicz AM, Spiridigliozzi GA, Tarleton J, Schoenwald S, et al. 1993. Evidence that methylation of the FMR-1 locus is responsible for variable phenotypic expression of the fragile X syndrome. Am. J. Hum. Genet. 53:800-9
114. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, et al. 1993. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 5:184-88
115. Miwa S. 1994. Triplet repeats strike again. Nat. Genet. 6:3-4
116. Monckton DG, Wong L-JC, Ashizawa T, Caskey CT. 1995. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum. Mol. Genet. 4:1-8
117. Mulley JC, Yu S, Loesch DZ, Hay DA, Donnelly A, et al. 1995. FRAXE and mental retardation. J. Med. Genet. 32:162-69
118. Myers RH, MacDonald ME, Korshetz WJ, Duyao MP, Ambrose CM, et al. 1993. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease Nat. Genet. 5:168-73
119. Nagafuchi S, Yanagisawa H, Oshaki E, Shirayama T, Tadokoro K, et al. 1994. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat. Genet. 8:177-82
120. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, et al. 1994. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinueleotide on chromosome 12p. Nat. Genet. 6:14-18
121. Naito H, Oyanagi S. 1982. Familial myoclonus epilepsy and choreoathetosis; hereditary dentatorubral-pallidoluysian atrophy. Neurology 32:798-807
122. Nakano KK, Dawson DM, Spence A. 1972. Machado-disease: a hereditary ataxia in Portuguese immigrants to Massachusetts. Neurology 22:49-55
123. Nancarrow JK, Holman K, Mangelsdorf M, Hori T, Demon M, et al. 1995. Molecular basis of p(CCG)n repeat instability at the FRA16A fragile site locus. Hunt. Mol. Genet. 4:367-72
124. Nancarrow JK, Kremer E, Holman K, Eyre H, Doggett NA, et al. 1994. Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science 264:1938-41
125. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, et al. 1995. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811-23
126. Oberlé I, Rousseau F, Heitz D, Kretz C, Devys D, et al. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-102
127. Orr HT, Chung M, Banfi S, Kwiatkowski TJ, Servadio A, et al. 1993. Expansion of an unstable trinueleotide (CAG) repeat in spinocerebellar ataxia type 1. Nat. Genet. 4:221-26
128. Otten AD, Tapscott SJ. 1995. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. USA 92:5465-69
129. Oudet C, Mornet E, Serre JL, Thomas F, Lentes-Zengerling SL, et al. 1993. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am. J. Hum. Genet. 52:297-304
130. Parrish JE, Oostra BA, Verkerk AJMH, Richards CS, Reynolds J, et al. 1994. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet. 8:229-35
131. Pieretti M, Zhang F, Fu YH, Warren ST, Oostra BA, et al. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-22
132. Potter NT, Meyer MA, Zimmerman AW, Eisenstadt ML, Anderson IJ. 1995. Molecular and clinical findings in a family with dentatorubral-pallidoluysian atrophy. Ann Neurol. 37:273-77
133. Quan F, Zonana J, Gunter K, Peterson KL, Magenis RE, Popovich BW. 1995. An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene. Am. J. Hum. Genet. 56:1042-51
134. Ranum LPW, Chung M-y, Banfi S, Bryer A, Schut LJ, et al. 1994. Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am. J. Hum. Genet. 55:244-52
135. Read A. 1993. Huntington's disease: testing the test. Nat. Genet. 4:329-30
136. Reyniers E, Vits L, De Boulle K, Van Roy B, Van Velzen D, et al. 1993. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat. Genet. 4:143-46
137. Richards RI. 1994. Simple repeat DNA is not replicated simply. Nat. Genet. 6:114-16
138. Richards RI, Holman K, Friend K, Kremer E, Hillen D, et al. 1992. Evidence of founder chromosomes in fragile X syndrome. Nat. Genet. 1:257-60
139. Riggins GJ, Lokey LK, Chastain JL, Leiner HA, Sherman SL, et al. 1992. Human genes containing polymorphic trinucleotide repeats. Nat. Genet. 2:186-91
140. Ritchie RJ, Knight SJL, Hirst MC, Grewal PK, Bobrow M, et al. 1994. The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter. Hum. Mol. Genet. 3:2115-21
141. Romain DR, Chapman CJ. 1992. Fragile site Xq27.3 in a family without mental retardation. Clin. Genet. 41:33-35
142. Rosenberg RN. 1992. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov. Disord 7:193-203
143. Rosenberg RN. 1995. Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 45:1-5
144. Rosenberg RN, Nyhan WL, Bay C. 1976. Autosomal dominant striatonigral degeneration: a clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 26:703-14
145. Rubinsztein DC, Amos W, Leggo J, Goodburn S, Ramesar RS, et al. 1994. Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence. Nat. Genet. 7:525-30
146. Sabourin LA, Mahadevan MS, Narang M, Lee DSC, Surh LC, Korneluk RG. 1993. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat. Genet. 4(3):233-38
147. Sano A, Yamauchi N, Kakimoto Y, Komure O, Kawai J, et al. 1994. Anticipation in hereditary dentatorubral-pallidoluysian atrophy. Hum. Genet. 93:699-702
148. Savage PD, Shapiro M, Langdon WY, Geurts van Kessel AD, Seuanez HN, et al. 1991. Relationship of the human protooncogene CBL2 on 11q23 to the t(4;11), t(11;22), t(11;14) breakpoints. Cytogenet. Cell Genet. 56:112-15
149. Schalling M, Hudson TJ, Buetow KH, Housman DE. 1993. Direct detection of novel expanded trinucleotide repeats in the human genome. Nal. Genet. 4:135-39
150. Schinzel A, auf der Maur P, Moser H. 1977. Partial deletion of long arm of chromosome 11[del(11)(q23)]: Jacobsen syndrome. J. Med. Genet. 14:438-44
151. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HT. 1995. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat. Genet. 10:94-98
152. Sharp AH, Loev SJ, Schilling G, Li S-H, Li X-J, et al. 1995. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065-74
153. Sherman SL, Jacobs PA, Morton NE, Froster-Iskenius U, Howard-Peebles PN, et al. 1985. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum. Genet. 69:289-99
154. Sherman SL, Morton NE, Jacobs PA, Turner G. 1984. The marker (X) syndrome: a cytogenetic and genetic analysis. Ann. Hum. Genet. 48:21-37
155. Siomi H, Choi M, Siomi NC, Nussbaum RL. Dreyfuss G. 1994. Essential role for the KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 causes fragile X syndrome. Cell 77:33-39
156. Siomi H, Matunis MJ, Michael WM, Dreyfuss G. 1993. The pre-mRNA bind- ing K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21(5):1193-98
157. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA binding protein. Cell 74:291-98
158. Smith JK, Gonda VE, Malamud N. 1958. Combined dentato-rubral and pallido-Luysian degeneration. Neurology 8:205-9
159. Smits APT, Dreesen JCFM, Post JG, Smeets DFCM, de Die-Smulders C, et al. 1993. The fragile X syndrome: no evidence for any recent mutations. J. Med. Genet. 30:94-96
160. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, et al. 1993. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4:393-97
161. Snow K, Tester DJ, Knickeberg KE, Schaid DJ, Thibodeau SN. 1994. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum. Mol. Genet. 3:1543-51
162. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. 1989. X-linked recessive bulbospinal neuronopathy. Brain 112:209-32
163. St. George-Hyslop P, Rogaeva E, Huterer J, Tsuda T, Santos J, et al. 1994. Machado-Joseph disease in pedigrees of Azorean descent is linked to chromosome 14. Am. J. Hum. Genet. 55:120-25
164. Stine OC, Li S-H, Pleasant N, Wagster MV, Hedreen JC, Ross CA. 1995. Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. Hum. Mol. Genet. 4:15-18
165. Stott K, Blackburn JM, Butler PJG, Penitz M. 1995. Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 92:6509-13
166. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, et al. 1993. Widespread expression of the human and ral Huntington's disease gene in brain and nonneuronal tissues. Nat. Genet. 5:259-65
167. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, et al. 1992. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1:397-400
168. Sutherland GR, Baker E. 1992. Charac- terization of a new rare fragile site easily confused with the fragile X. Hum. Mol Genet. 1:111-13
169. Sutherland GR, Gedeon A, Kornman L, Donnelly A, Byard RW, et al. 1991. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N. Engl. J. Med. 325:1720-22
170. Sutherland GR, Jacky PB, Baker E, Manuel A. 1983. Heritable fragile sites on human chromosomes. X. New folate-sensitive fragile sites: 6p23, 9p21, 9q32, 11q23. Am. J. Hum. Genet. 35:432-37
171. Sutherland GR, Richards RI. 1995. Simple tandem DNA repeats and human genetic disease. Proc. Natl. Acad. Sci. USA 92:3636-41
172. Takahashi H, Ohama E, Naito H, Takeda S, Nakashima S, et al. 1988. Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathological variants in a family. Neurology 38:1065-70
173. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. 1995. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol 128:995-1002
174. Telenius H, Almqvist E, Kremer B, Spence N, Squitieri F, et al. 1995. Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease. Hum. Mol. Genet. 4:189-95
175. Trottier Y, Devys D, Imbert G, Saudou F, An I, et al. 1995. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat. Genet. 10:104-10
176. Tsilfidis C, Mackenzie AE, Mettler G, Barcelo J, Korneluk RG. 1992. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat. Genet. 1:192-95
177. Tunnacliffe A, Mcguire RS. 1990. A physical linkage group in human chromosome band 11q23 covering a region implicated in leukocyte neoplasia. Genomics 8:447-53
178. Ueno S-i, Kondoh K, Kotani Y, Komure O, Kuno S, et al. 1995. Somatic mosaicism of CAG repeal in dentatorubral-pallidoluysian atrophy (DRPLA). Hum. Mol. Genet. 4:663-66
179. van der Veil PFM, Jansen G, van Kuppevell THMSM, Ferryman MB, Lu pa M, et al. 1993. Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum. Mol. Genet. 2:1889-94
180. Verheij C, Bakker CE, deGraaff E, Keulemans J, Willemson R, et al. 1993.
181. Verheij C, de Graaff E, Bakker CE, Willemson R, Willems PJ, et al. 1995. Characterization of FMR1 proteins isolated from different tissues. Hum. Mol. Genet. 4:895-901
182. Verkerk AJMH, de Graaff E, De Boulle K, Eichler EE, Konecki DS, et al. 1993. Alternative splicing in the fragile X gene FMR1. Hum. Mol. Genet. 2(4):399-404
183. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DPA, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-14
184. Voullaire LE, Webb GC, Leversha MA. 1987. Chromosome deletion at 11q23 in an abnormal child from a family with inherited fragility at 11q23. Hum. Genet. 76:202-4
185. Wang J, Pegoraro E, Menegazzo E, Gennarelli M, Hoop RC, et al. 1995. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4:599-606
186. Wang Y-H, Amirhaeri S, Kang S, Wells RD, Griffith JD. 1994. Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 265:669-71
187. Wang Y-H, Griffith J. 1995. Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements. Genomics 25:570-73
188. Warner TT, Williams L, Harding AE. 1994. DRPLA in Europe. Nat. Genet. 6:225
189. Warner TT, Williams LD, Walker RWH, Flinter F, Robb SA, et al. 1995. A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four European families. Ann. Neurol. 37:452-59
190. Warren ST, Ashley CT. 1995. Triplet repeat expansion mutations: the example of fragile X syndrome. Annu. Rev. Neurosci. 18:77-99
191. Warren ST, Nelson DL. 1993. Trinucleotide repeat expansions in neurologic disease. Curr. Opin. Neurobiol. 3:752-59
192. Warren ST, Nelson DL. 1994. Advances in molecular analysis of fragile X syndrome. J Am. Med. Assoc. 271:536-42
193. Whiting EJ, Waring JD, Tamai K, Somerville MJ, Hincke M, et al. 1995. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. Hum. Mol. Genet. 4:1063-72
194. Willems PJ, Van Roy B, De Boulle K, Vils L, Reyniers E, et al. 1992. Segregation of the fragile X mutation from an affected male to his normal daughter. Hum. Mol. Genet. 1(7):511-17
195. Wohrle D, Mennig I, Vogel W, Steinbach P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat. Genet. 4:140-42
196. Wong L-JC, Ashizawa T, Monckton DG, Caskey CT, Richards CS. 1995. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am. J. Hum. Genet. 56:114-22
197. Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawa I. 1995. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. Nat. Genet. 10:99-103
198. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, et al. 1991. Fragile X genotype characterized by an unstable region of DNA. Science 252:1179-81
199. Yunis JJ, Soreng AL. 1984. Constitutive fragile sites and cancer. Science 226:1199-204
200. Zatz M, Passos-Bueno MR, Cerqueira A, Marie SK, Vainzof M, Pavanello RCM. 1995. Analysis of the CTG repeat in skeletal muscle of young and adult myolonic dystrophy patients: when does the expansion occur. Hum. Mol. Genet. 4:401-6
201. Zerylnick C, Torroni A, Sherman SL, Warren ST. 1995. Normal variation at the myotonic dystrophy locus in global human populations. Am. J. Hum. Genet. 56:123-30
202. Zhang L, Fischbeck KH, Arnheim N. 1995. CAG repeat length variation in sperm from a patient with Kennedy's disease. Hum. Mol. Genet. 4:303-5
203. Zhang L, Leeflang EP, Yu JY, Arnheim N. 1994. Studying human mutations by sperm typing: instability of CAG trinucleotide repeats in the human androgen receptor gene. Nat. Genet. 7:531-35
204. Zoghbi HY. 1993. The spinocerebellar degenerations. In Current Neurology, ed. SH Appel, pp. 87-110. St. Louis: Mosby-Year Book
205. Zoghbi HY, Pollack MS, Lyons LA, Ferrell RE, Daiger SP, Beaudet AL. 1988. Spinocerebellar alaxia: variable age of onset and linkage to human leukocyte antigen in a large kindred. Ann. Neurol. 25:580-84
206. Zuhlke C, Riess O, Bockel B, Lange H, Thies U. 1993. Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum. Mol. Genet. 2:2063-67